Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2026-01-07 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
144 Report of proposed sale of securities 2 pages 144.1KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details insider sales of securities by a company director, including number of shares, dates, and broker information. This type of filing is specifically related to personal share transactions by company directors and executives (insider trades). It is not an earnings release, annual report, or any other financial report. Therefore, the correct classification is Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2026-01-07 English
144 Report of proposed sale of securities 2 pages 131.8KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of restricted stock by an insider or affiliate, including information about the securities, the seller, and the broker. This type of filing is specifically related to insider sales and transactions in securities by company insiders or affiliates. It is not an annual report, earnings release, or any other financial report. It is a regulatory filing notifying the SEC and the public about the proposed sale of securities by an insider. Therefore, the appropriate classification is 'DIRS' (Director's Dealing). The document length is 4222 characters, which is consistent with a detailed insider transaction notice rather than a brief announcement or a full report.
2026-01-05 English
144 Report of proposed sale of securities 3 pages 136.3KB
Regulatory Filings Classification · 100% confidence The document is a Form 144 filing, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It contains detailed information about the filer, issuer, securities to be sold, acquisition details, and sales in the past 3 months. This form is used to notify the SEC and the public about insider or affiliate sales of restricted or control securities. It is not an annual report, earnings release, or any other financial report but a regulatory filing related to insider transactions. Therefore, it fits best under Regulatory Filings (RNS). The document length is 4583 characters, and it contains substantive data specific to the Form 144 filing, not just an announcement or certification.
2026-01-05 English
Statement of CDIs on issue - RMD 3 pages 12.4KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and details the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly statements of securities issued, net transfers, and reasons for changes such as transfers, stock options, employee stock purchase plans, and share repurchases. The document is short (3044 characters) and is a regulatory announcement related to securities on issue rather than a financial report or detailed analysis. It does not contain financial statements, management discussion, or audit information. This type of document is a regulatory filing related to securities and shareholding but does not fit into more specific categories like Major Shareholding Notification or Transaction in Own Shares because it is a routine statement of securities on issue. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2026-01-05 English
144 Report of proposed sale of securities 3 pages 139.8KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details insider sales of shares by a company officer or director, including the number of shares, dates, and broker information. This type of filing is specifically related to insider transactions by directors or officers. It is not an annual report, earnings release, or any other financial report. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2025-12-09 English
4 Statement of changes in beneficial ownership 2 pages 13.4KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC), which reports changes in beneficial ownership of company securities by insiders such as directors and officers. It includes detailed tables of transactions involving common stock and stock options by Michael J. Farrell, Chairman and CEO of ResMed Inc. The form is specifically used to disclose insider transactions under Section 16(a) of the Securities Exchange Act of 1934. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other type of financial or regulatory report but a specific insider transaction report.
2025-12-09 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.